<DOC>
	<DOCNO>NCT00402103</DOCNO>
	<brief_summary>To assess long-term ( 6 month 12 month ) safety combination aliskiren 300 mg / amlodipine 10 mg patient essential hypertension ( Mean Sitting Diastolic Blood Pressure [ msDBP ] ≥ 90 mmHg &lt; 110 mmHg ) .</brief_summary>
	<brief_title>An Assessment Long Term Safety Combination Aliskiren / Amlodipine Patients With High Blood Pressure</brief_title>
	<detailed_description />
	<mesh_term>Hypertension</mesh_term>
	<mesh_term>Hydrochlorothiazide</mesh_term>
	<mesh_term>Amlodipine</mesh_term>
	<criteria>Outpatients 18 year age old Male female patient eligible For newly diagnosed/untreated patient essential hypertension define msDBP ≥ 90 &lt; 110 mmHg Visit 1 Visit 4 For previously treat patient essential hypertension define msDBP ≥ 90 &lt; 110 mmHg 2 4 week washout ( Visit 4 ) Severe hypertension History evidence secondary form hypertension History Hypertensive encephalopathy cerebrovascular accident . Other protocoldefined inclusion/exclusion criterion may apply</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>March 2011</verification_date>
	<keyword>Hypertension , aliskiren , amlodipine , HCTZ , blood pressure</keyword>
</DOC>